Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 13 publications
1
0
0
Order By: Relevance
“…Since anti-CD38 monoclonal antibodies in particular combined with Carfilzomib or Pomalidomide are highly effective against advanced myeloma cells we have attempted to treat a patient presenting with pleural EMD. Our results in view of the published similar reports favour this combination as a bridging therapy to stem cell transplantation (10). Among recent randomized clinical trials EMD is gradually being recognized as a risk factor but response rate and durations are rarely reported.…”
Section: Months)supporting
confidence: 82%
“…Since anti-CD38 monoclonal antibodies in particular combined with Carfilzomib or Pomalidomide are highly effective against advanced myeloma cells we have attempted to treat a patient presenting with pleural EMD. Our results in view of the published similar reports favour this combination as a bridging therapy to stem cell transplantation (10). Among recent randomized clinical trials EMD is gradually being recognized as a risk factor but response rate and durations are rarely reported.…”
Section: Months)supporting
confidence: 82%